SCI Pharmtech, Inc. (4119.TW)
TWD 89.9
(-0.66%)
TWD 89.9
(-0.66%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 2.70 TWD | -4.59% |
| 2022 | 2.83 TWD | 454.9% |
| 2021 | 0.51 TWD | -84.55% |
| 2020 | 3.30 TWD | -37.02% |
| 2019 | 5.24 TWD | 25.66% |
| 2018 | 4.17 TWD | 132.96% |
| 2017 | 1.79 TWD | -54.8% |
| 2016 | 3.96 TWD | 3.39% |
| 2015 | 3.83 TWD | 34.86% |
| 2014 | 2.84 TWD | 65.12% |
| 2013 | 1.72 TWD | -33.33% |
| 2012 | 2.58 TWD | 122.41% |
| 2011 | 1.16 TWD | -47.98% |
| 2010 | 2.23 TWD | 1.36% |
| 2009 | 2.20 TWD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.52 TWD | 40.54% |
| 2024 Q1 | 0.37 TWD | 1325.17% |
| 2023 Q3 | 0.32 TWD | -80.37% |
| 2023 Q4 | -0.03 TWD | -109.44% |
| 2023 Q1 | 0.58 TWD | -19.44% |
| 2023 Q2 | 1.63 TWD | 181.03% |
| 2023 FY | - TWD | -4.59% |
| 2022 Q2 | 1.47 TWD | 241.86% |
| 2022 FY | - TWD | 454.9% |
| 2022 Q1 | 0.43 TWD | 315.0% |
| 2022 Q4 | 0.72 TWD | 41.18% |
| 2022 Q3 | 0.51 TWD | -65.31% |
| 2021 Q1 | 0.38 TWD | 112.97% |
| 2021 Q3 | 0.28 TWD | 686.52% |
| 2021 Q2 | 0.04 TWD | -90.63% |
| 2021 FY | - TWD | -84.55% |
| 2021 Q4 | -0.20 TWD | -171.43% |
| 2020 FY | - TWD | -37.02% |
| 2020 Q2 | 2.25 TWD | 15.98% |
| 2020 Q3 | 1.76 TWD | -21.78% |
| 2020 Q4 | -2.93 TWD | -266.48% |
| 2020 Q1 | 1.94 TWD | 106.38% |
| 2019 Q1 | 1.53 TWD | 31.9% |
| 2019 Q4 | 0.94 TWD | -36.91% |
| 2019 FY | - TWD | 25.66% |
| 2019 Q3 | 1.49 TWD | 1.36% |
| 2019 Q2 | 1.47 TWD | -3.92% |
| 2018 Q3 | 1.19 TWD | -14.39% |
| 2018 FY | - TWD | 132.96% |
| 2018 Q4 | 1.16 TWD | -2.52% |
| 2018 Q2 | 1.39 TWD | 143.86% |
| 2018 Q1 | 0.57 TWD | -8.06% |
| 2017 Q4 | 0.62 TWD | 63.16% |
| 2017 FY | - TWD | -54.8% |
| 2017 Q1 | 0.48 TWD | 33.33% |
| 2017 Q2 | 0.37 TWD | -22.92% |
| 2017 Q3 | 0.38 TWD | 2.7% |
| 2016 Q1 | 1.53 TWD | 112.5% |
| 2016 Q3 | 0.88 TWD | -30.71% |
| 2016 Q4 | 0.36 TWD | -59.09% |
| 2016 FY | - TWD | 3.39% |
| 2016 Q2 | 1.27 TWD | -16.99% |
| 2015 Q1 | 0.99 TWD | 73.68% |
| 2015 Q2 | 1.33 TWD | 34.34% |
| 2015 FY | - TWD | 34.86% |
| 2015 Q3 | 0.99 TWD | -25.56% |
| 2015 Q4 | 0.72 TWD | -27.27% |
| 2014 Q2 | 1.00 TWD | 47.06% |
| 2014 Q4 | 0.57 TWD | -12.31% |
| 2014 FY | - TWD | 65.12% |
| 2014 Q1 | 0.68 TWD | 25.93% |
| 2014 Q3 | 0.65 TWD | -35.0% |
| 2013 FY | - TWD | -33.33% |
| 2013 Q3 | 0.24 TWD | -60.66% |
| 2013 Q4 | 0.54 TWD | 125.0% |
| 2013 Q2 | 0.61 TWD | -14.08% |
| 2013 Q1 | 0.71 TWD | -14.46% |
| 2012 Q2 | 0.46 TWD | -36.99% |
| 2012 Q1 | 0.73 TWD | 258.7% |
| 2012 Q4 | 0.83 TWD | 33.87% |
| 2012 Q3 | 0.62 TWD | 34.78% |
| 2012 FY | - TWD | 122.41% |
| 2011 Q3 | 0.55 TWD | 5.77% |
| 2011 Q1 | 0.62 TWD | -3.13% |
| 2011 Q2 | 0.52 TWD | -16.13% |
| 2011 FY | - TWD | -47.98% |
| 2011 Q4 | -0.46 TWD | -183.64% |
| 2010 FY | - TWD | 1.36% |
| 2010 Q2 | 0.71 TWD | 31.48% |
| 2010 Q1 | 0.54 TWD | 0.0% |
| 2010 Q4 | 0.64 TWD | 16.36% |
| 2010 Q3 | 0.55 TWD | -22.54% |
| 2009 FY | - TWD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Grape King Bio Ltd | 9.81 TWD | 72.477% |
| Standard Chem & Pharm CO., LTD. | 4.67 TWD | 42.184% |
| Maywufa Company Ltd. | 1.27 TWD | -112.598% |
| ScinoPharm Taiwan, Ltd. | 0.36 TWD | -650.0% |
| Lotus Pharmaceutical Co., Ltd. | 15.72 TWD | 82.824% |
| LIWANLI Innovation Co., Ltd. | 0.06 TWD | -4165.403% |
| YungShin Global Holding Corporation | 3.11 TWD | 13.183% |
| PhytoHealth Corporation | -0.24 TWD | 1225.0% |
| Formosa Laboratories, Inc. | 1.05 TWD | -157.143% |
| PharmaEssentia Corporation | -1.93 TWD | 239.896% |
| Bora Pharmaceuticals Co., LTD. | 30.20 TWD | 91.06% |